Estée Lauder beat on both the top and bottom lines despite weak demand. See why EL stock is undervalued following a tough quarter but strong margin improvement.

Barclays analyst Lauren Lieberman lowered the firm’s price target on Estee Lauder (EL) to $64 from $71 and keeps an Equal Weight rating on the ...

In a report released today, Dara Mohsenian from Morgan Stanley maintained a Hold rating on The Estée Lauder Companies (EL – Research Report), ...

Estée Lauder reported another quarter of weak sales and declining margins as its China and travel businesses struggle. Read ...

Estee Lauder may trim more than 11% of its workforce after the global beauty cosmetics maker lost money in its most recent ...

This was the stock's fourth consecutive day of losses.

The company anticipates restructuring and other charges of between $1.2bn and $1.6bn as it overhauls the business.

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

The Bank of England is poised to cut its benchmark interest rate to 4.5% amid the UK’s economic slowdown and ongoing ...

Super Micro Computer stock was rising ahead of Thursday’s opening bell, putting the artificial intelligence server maker on course for further gains. It’s finally giving investors reason to feel ...